Author:
Alharf A A,Cleland S,Webster J,McInnes G T,Padmanabhan S
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Pascual JM, Rodilla E, Costa JA, Garcia-Escrich M, Gonzalez C, Redon J . Prognostic value of microalbuminuria during antihypertensive treatment in essential hypertension. Hypertension 2014; 64: 1228–1234.
2. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR . Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63: 225–232.
3. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421–426.
4. National Collaborating Centre for Chronic Conditions Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). Royal College of Physicians: London, 2008 cited 12 December 2011; Available from: http://www.ncbi.nlm.nih.gov/books/NBK53885/pdf/TOC.pdf.
5. Pedrinelli R, Dell'Omo G, Penno G, Di Bello V, Giorgi D, Pellegrini G et al. Microalbuminuria, a parameter independent of metabolic influences in hypertensive men. J Hypertens 2003; 21: 1163–1169.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献